Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by aussyspitzon Jun 30, 2020 9:41pm
165 Views
Post# 31210940

To be fair

To be fairAt least they didn't say H2 2020 the fact that they said Q3 depending on your perspective is somewhat encouraging for current holders. In my personal opinion the recent share price rise was already nearly fully baked in for BLA submission based on their anticipated previous H1 2020 claim. However, given their cash burn rate even IF the BLA submission actually occurs in Q3 any short term share price bump is going to fade very quickly due to the reality that they will need to raise funds my guess is via a discounted pp which will line the bankers pockets but further dilute/erode retail investors stake. Imo this stock may make some daytraders some cash playing on its volatility but there are significantly better long term plays available for serious investors and even better speculative plays. Previous claims on this board of $50 to $100 a share by years end are about as realistic as me getting a date with Elsa Hosk
<< Previous
Bullboard Posts
Next >>